Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens
Mark Laible(BioNTech (Germany)), Uğur Şahin(Johannes Gutenberg University Mainz), Sotiris Lakis, Arndt Hartmann(Universitätsklinikum Erlangen), Elke Veltrup(Siemens Healthcare (Germany)), Ralph M. Wirtz(Siemens Healthcare (Germany)), Kornelia Schlombs(BioNTech (Germany)), Sebastian Eidt(St. Elisabeth-Hospital Bochum), Katharina Kaiser(Fraunhofer Institute for Process Engineering and Packaging), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stefanie Herlein(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 55
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
mRNA-based therapeutics — developing a new class of drugs
|Nature Reviews Drug Discovery|2014|2.4k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k